Cargando…
Toxicity Testing in the 21(st) Century: Defining New Risk Assessment Approaches Based on Perturbation of Intracellular Toxicity Pathways
The approaches to quantitatively assessing the health risks of chemical exposure have not changed appreciably in the past 50 to 80 years, the focus remaining on high-dose studies that measure adverse outcomes in homogeneous animal populations. This expensive, low-throughput approach relies on conser...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118802/ https://www.ncbi.nlm.nih.gov/pubmed/21701582 http://dx.doi.org/10.1371/journal.pone.0020887 |
_version_ | 1782206509247102976 |
---|---|
author | Bhattacharya, Sudin Zhang, Qiang Carmichael, Paul L. Boekelheide, Kim Andersen, Melvin E. |
author_facet | Bhattacharya, Sudin Zhang, Qiang Carmichael, Paul L. Boekelheide, Kim Andersen, Melvin E. |
author_sort | Bhattacharya, Sudin |
collection | PubMed |
description | The approaches to quantitatively assessing the health risks of chemical exposure have not changed appreciably in the past 50 to 80 years, the focus remaining on high-dose studies that measure adverse outcomes in homogeneous animal populations. This expensive, low-throughput approach relies on conservative extrapolations to relate animal studies to much lower-dose human exposures and is of questionable relevance to predicting risks to humans at their typical low exposures. It makes little use of a mechanistic understanding of the mode of action by which chemicals perturb biological processes in human cells and tissues. An alternative vision, proposed by the U.S. National Research Council (NRC) report Toxicity Testing in the 21(st) Century: A Vision and a Strategy, called for moving away from traditional high-dose animal studies to an approach based on perturbation of cellular responses using well-designed in vitro assays. Central to this vision are (a) “toxicity pathways” (the innate cellular pathways that may be perturbed by chemicals) and (b) the determination of chemical concentration ranges where those perturbations are likely to be excessive, thereby leading to adverse health effects if present for a prolonged duration in an intact organism. In this paper we briefly review the original NRC report and responses to that report over the past 3 years, and discuss how the change in testing might be achieved in the U.S. and in the European Union (EU). EU initiatives in developing alternatives to animal testing of cosmetic ingredients have run very much in parallel with the NRC report. Moving from current practice to the NRC vision would require using prototype toxicity pathways to develop case studies showing the new vision in action. In this vein, we also discuss how the proposed strategy for toxicity testing might be applied to the toxicity pathways associated with DNA damage and repair. |
format | Online Article Text |
id | pubmed-3118802 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-31188022011-06-23 Toxicity Testing in the 21(st) Century: Defining New Risk Assessment Approaches Based on Perturbation of Intracellular Toxicity Pathways Bhattacharya, Sudin Zhang, Qiang Carmichael, Paul L. Boekelheide, Kim Andersen, Melvin E. PLoS One Review The approaches to quantitatively assessing the health risks of chemical exposure have not changed appreciably in the past 50 to 80 years, the focus remaining on high-dose studies that measure adverse outcomes in homogeneous animal populations. This expensive, low-throughput approach relies on conservative extrapolations to relate animal studies to much lower-dose human exposures and is of questionable relevance to predicting risks to humans at their typical low exposures. It makes little use of a mechanistic understanding of the mode of action by which chemicals perturb biological processes in human cells and tissues. An alternative vision, proposed by the U.S. National Research Council (NRC) report Toxicity Testing in the 21(st) Century: A Vision and a Strategy, called for moving away from traditional high-dose animal studies to an approach based on perturbation of cellular responses using well-designed in vitro assays. Central to this vision are (a) “toxicity pathways” (the innate cellular pathways that may be perturbed by chemicals) and (b) the determination of chemical concentration ranges where those perturbations are likely to be excessive, thereby leading to adverse health effects if present for a prolonged duration in an intact organism. In this paper we briefly review the original NRC report and responses to that report over the past 3 years, and discuss how the change in testing might be achieved in the U.S. and in the European Union (EU). EU initiatives in developing alternatives to animal testing of cosmetic ingredients have run very much in parallel with the NRC report. Moving from current practice to the NRC vision would require using prototype toxicity pathways to develop case studies showing the new vision in action. In this vein, we also discuss how the proposed strategy for toxicity testing might be applied to the toxicity pathways associated with DNA damage and repair. Public Library of Science 2011-06-20 /pmc/articles/PMC3118802/ /pubmed/21701582 http://dx.doi.org/10.1371/journal.pone.0020887 Text en Bhattacharya et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Review Bhattacharya, Sudin Zhang, Qiang Carmichael, Paul L. Boekelheide, Kim Andersen, Melvin E. Toxicity Testing in the 21(st) Century: Defining New Risk Assessment Approaches Based on Perturbation of Intracellular Toxicity Pathways |
title | Toxicity Testing in the 21(st) Century: Defining New Risk Assessment Approaches Based on Perturbation of Intracellular Toxicity Pathways |
title_full | Toxicity Testing in the 21(st) Century: Defining New Risk Assessment Approaches Based on Perturbation of Intracellular Toxicity Pathways |
title_fullStr | Toxicity Testing in the 21(st) Century: Defining New Risk Assessment Approaches Based on Perturbation of Intracellular Toxicity Pathways |
title_full_unstemmed | Toxicity Testing in the 21(st) Century: Defining New Risk Assessment Approaches Based on Perturbation of Intracellular Toxicity Pathways |
title_short | Toxicity Testing in the 21(st) Century: Defining New Risk Assessment Approaches Based on Perturbation of Intracellular Toxicity Pathways |
title_sort | toxicity testing in the 21(st) century: defining new risk assessment approaches based on perturbation of intracellular toxicity pathways |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118802/ https://www.ncbi.nlm.nih.gov/pubmed/21701582 http://dx.doi.org/10.1371/journal.pone.0020887 |
work_keys_str_mv | AT bhattacharyasudin toxicitytestinginthe21stcenturydefiningnewriskassessmentapproachesbasedonperturbationofintracellulartoxicitypathways AT zhangqiang toxicitytestinginthe21stcenturydefiningnewriskassessmentapproachesbasedonperturbationofintracellulartoxicitypathways AT carmichaelpaull toxicitytestinginthe21stcenturydefiningnewriskassessmentapproachesbasedonperturbationofintracellulartoxicitypathways AT boekelheidekim toxicitytestinginthe21stcenturydefiningnewriskassessmentapproachesbasedonperturbationofintracellulartoxicitypathways AT andersenmelvine toxicitytestinginthe21stcenturydefiningnewriskassessmentapproachesbasedonperturbationofintracellulartoxicitypathways |